PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 28.417
EU - Europa 22.864
AS - Asia 15.868
SA - Sud America 1.879
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 312
OC - Oceania 43
Totale 69.718
Nazione #
US - Stati Uniti d'America 28.010
RU - Federazione Russa 6.975
SG - Singapore 6.721
GB - Regno Unito 6.275
CN - Cina 4.952
IT - Italia 2.226
BR - Brasile 1.538
SE - Svezia 1.517
DE - Germania 1.313
FR - Francia 1.264
HK - Hong Kong 1.169
VN - Vietnam 1.128
FI - Finlandia 1.123
IE - Irlanda 1.113
KR - Corea 519
UA - Ucraina 420
BD - Bangladesh 230
IN - India 220
CA - Canada 207
JP - Giappone 194
TR - Turchia 160
AR - Argentina 125
BE - Belgio 121
MX - Messico 108
NL - Olanda 95
NG - Nigeria 84
ID - Indonesia 81
PL - Polonia 80
ES - Italia 78
IQ - Iraq 77
ZA - Sudafrica 74
IR - Iran 62
PK - Pakistan 58
EC - Ecuador 54
UZ - Uzbekistan 39
VE - Venezuela 37
AU - Australia 33
CO - Colombia 33
MA - Marocco 33
CZ - Repubblica Ceca 32
PY - Paraguay 28
RO - Romania 28
CH - Svizzera 26
LT - Lituania 26
AT - Austria 25
AE - Emirati Arabi Uniti 23
AZ - Azerbaigian 21
CL - Cile 21
EG - Egitto 20
SA - Arabia Saudita 20
KE - Kenya 19
NP - Nepal 19
PE - Perù 19
IL - Israele 18
PH - Filippine 18
BG - Bulgaria 17
MY - Malesia 17
KG - Kirghizistan 14
TN - Tunisia 14
BO - Bolivia 13
DZ - Algeria 13
EU - Europa 13
JM - Giamaica 13
JO - Giordania 13
PA - Panama 13
AL - Albania 12
CR - Costa Rica 12
LB - Libano 11
RS - Serbia 11
TT - Trinidad e Tobago 11
KZ - Kazakistan 10
LV - Lettonia 9
NZ - Nuova Zelanda 9
SN - Senegal 9
UY - Uruguay 9
HN - Honduras 8
HU - Ungheria 8
PS - Palestinian Territory 8
PT - Portogallo 8
DK - Danimarca 7
HR - Croazia 7
OM - Oman 7
SY - Repubblica araba siriana 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
SK - Slovacchia (Repubblica Slovacca) 6
TG - Togo 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
GA - Gabon 5
KW - Kuwait 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
AM - Armenia 4
BJ - Benin 4
CY - Cipro 4
Totale 69.299
Città #
Southend 5.299
Jacksonville 3.691
Singapore 3.689
Ashburn 3.060
Chandler 2.484
Dallas 2.390
Moscow 2.162
Woodbridge 2.117
San Jose 2.055
Ann Arbor 1.394
Houston 1.205
Hong Kong 1.146
Dublin 1.111
The Dalles 748
Council Bluffs 746
Beijing 658
Verona 658
Wilmington 473
Los Angeles 447
Lawrence 445
Princeton 445
Jinan 444
New York 424
Nanjing 413
Ho Chi Minh City 368
Shenyang 353
Buffalo 282
Hanoi 265
Hebei 229
Helsinki 211
Tianjin 210
Boardman 202
Sindelfingen 185
Munich 179
Milan 176
Santa Clara 172
Columbus 158
Changsha 154
São Paulo 153
Zhengzhou 153
Nanchang 142
Haikou 131
Hangzhou 127
Ningbo 124
Brussels 113
Taizhou 113
Tokyo 113
Jiaxing 107
Orem 103
Seattle 100
Guangzhou 99
Philadelphia 97
Redondo Beach 86
Taiyuan 86
Washington 83
Turku 79
Rome 76
Falls Church 75
London 74
Seoul 74
Frankfurt am Main 73
Norwalk 71
Abuja 70
Lancaster 69
Montreal 68
San Francisco 67
Chennai 63
Chicago 62
Brooklyn 60
Warsaw 60
Toronto 59
Dearborn 57
Fuzhou 57
Auburn Hills 56
Denver 53
Düsseldorf 51
Stockholm 51
Rio de Janeiro 50
Redmond 49
Boston 48
Fairfield 47
Manchester 47
Da Nang 46
Lanzhou 46
Phoenix 46
Amsterdam 45
Atlanta 45
Jakarta 44
Haiphong 43
Johannesburg 37
Mumbai 34
Shanghai 33
Tashkent 33
Paris 31
Bologna 30
Cambridge 30
Dong Ket 30
Biên Hòa 29
Brasília 29
Madrid 29
Totale 45.104
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 474
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 444
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 438
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 325
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 314
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 309
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 296
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 296
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 295
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 288
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 286
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 279
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 275
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 270
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 268
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 263
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 261
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 259
A rapid immunostaining method for frozen sections 257
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 253
A study of the crosstalk between CD30 and CXCR4 252
Acute leukemia and pregnancy. Case report 250
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 250
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 248
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 246
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 245
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 244
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 243
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 243
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 243
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 242
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 240
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 239
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 238
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 238
BCR-signaling profiles associated with prognosis and progression in B-CLL 238
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 236
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 236
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 234
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 233
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 231
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 231
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 230
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 229
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 229
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 229
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 228
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 228
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 226
Blastic OKT6-positive proliferation preceding malignant histiocytosis 223
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 223
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
BCR-signaling profiles associated with prognosis and progression in B-CLL 222
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 221
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 220
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 219
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 218
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 217
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 217
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 214
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 214
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 213
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 213
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 212
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 211
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 211
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 211
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 209
[Haemolytic anaemia associated with acquired deficiency of erythrocyte glutathione peroxidase: use of sodium selenite to correct the enzyme defect (author's transl)] 208
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 207
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 207
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 207
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 206
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 205
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 205
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 204
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 203
An unusual case of acute leukaemia 202
[Immunology of the lymphatic follicle] 202
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 202
G-CSF-stimulated neutrophils are a prominent source of functional B-lymphocyte stimulator (BLyS) 202
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 201
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 201
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 201
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 201
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 201
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 198
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 197
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 197
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 195
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 195
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 194
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 194
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 194
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 193
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations 193
Biological prognostic factors in indolent lymphoma 193
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance 192
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function 192
Totale 23.568
Categoria #
all - tutte 217.654
article - articoli 156.787
book - libri 0
conference - conferenze 58.074
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.793
Totale 435.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.481 0 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20258.611 600 595 220 1.458 472 279 318 383 1.323 475 706 1.782
2025/202624.179 1.866 1.831 1.905 3.535 5.636 1.730 2.436 1.257 1.776 1.372 396 439
2026/20271.034 342 692 0 0 0 0 0 0 0 0 0 0
Totale 69.718